Taro Pharmaceutical Industries Ltd
0 DAYS LEFT TO SEEK LEAD PLAINTIFF STATUS
Case Summary | |
Company Name: | Taro Pharmaceutical Industries Ltd |
Stock Symbol : | NYSE: TARO |
Class Period Start: | 07/03/2014 |
Class Period End: | 09/09/2016 |
Lead Plaintiff motion: | 12/27/2016 |
Date Filed: | 10/25/2016 |
Type of Case: | Securities Class Action |
Court: | U.S. District Court for the Southern District of New York |
Summary: | Thieler Law Corp advises investors with losses exceeding $100,000 of the December 27, 2016 lead plaintiff deadline in a class action lawsuit filed against Taro Pharmaceutical Industries Ltd (NYSE: TARO) (“Taro Pharmaceutical” or “the Company”). The suit is pending in the U.S. District Court for the Southern District of New York and investors, who purchased Taro Pharmaceutical Industries Ltd securities between July 3, 2014 and September 9, 2016, have until December 27, 2016 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class. If you purchased Taro Pharmaceutical Industries Ltd securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class. The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that since 2014 Taro Pharmaceutical has colluded with other pharmaceutical companies to keep the price of generic products artificially high; the foregoing conduct violated federal antitrust laws; in turn, Taro Pharmaceutical's revenues during the Class Period were the result of illegal conduct; and as a result, the Company's public statements were materially false and misleading at all relevant times. On September 9, 2016, Taro Pharmaceutical revealed the receipt of grand jury subpoenas in relation with a federal antitrust investigation into generic drug pricing. Then on October 17, 2016, NECA-IBEW Welfare Trust Fund filed an antitrust class action lawsuit against Taro Pharmaceutical and numerous other pharmaceutical companies alleging involvement in the price-fixing of Clobetasol since 2014. If you were negatively impacted by your investment in Taro Pharmaceutical Industries Ltd securities between July 3, 2014 and September 9, 2016 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation. Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Thieler Law Corp 2534 State Street - Suite 406, San Diego, CA 92101 by email: mail@thielerlaw.com or telephone at +1 (619) 377 - 4324 or visit our website http://www.thielerlaw.com/ or Facsimile: +1 (619) 785 – 3185 |